Identification of a Negative Regulatory Surface within Estrogen Receptor α Provides Evidence in Support of a Role for Corepressors in Regulating Cellular Responses to Agonists and Antagonists-Reference-Cited by-同舟云学术

Identification of a Negative Regulatory Surface within Estrogen Receptor α Provides Evidence in Support of a Role for Corepressors in Regulating Cellular Responses to Agonists and Antagonists

Published:2002-08-01 Issue:8 Volume:16 Page:1778-1792
ISSN:0888-8809
Container-title:Molecular Endocrinology
language:en
Short-container-title:

Author:

Huang Huey-Jing¹,Norris John D.¹,McDonnell Donald P.¹

Affiliation:

1. Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710

Publisher

The Endocrine Society

Subject

Endocrinology,Molecular Biology,General Medicine

Link

http://academic.oup.com/mend/article-pdf/16/8/1778/8963150/mend1778.pdf

Reference39 articles.

1. Several regions of human estrogen receptor are involved in the formation of receptor-heat shock protein 90 complexes.;Chambraud;J Biol Chem,1990

2. Steroid receptor interactions with heat shock protein and immunophilin chaperones.;Pratt;Endocr Rev,1997

3. Hormone-dependent transactivation by estrogen receptor chimeras that do not interact with hsp90. Evidence for transcriptional repressors.;Lee;J Biol Chem,1996

4. Cloning of a novel receptor expressed in rat prostate and ovary.;Kuiper;Proc Natl Acad Sci USA,1996

5. Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α.;Pettersson;Mol Endocrinol,1997

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells;Cancer Letters;2021-10

2. Dual-mechanism estrogen receptor inhibitors;Proceedings of the National Academy of Sciences;2021-08-27

3. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer;Nucleic Acids Research;2020-09-28

4. Dual mechanism estrogen receptor inhibitors;2020-07-06

5. The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor;Molecular Cancer Therapeutics;2020-05-07